LEADER 01225nam  22004095u 450 
001 9910158699203321
005 20211006144822.0
010   $a3-318-04083-5
035   $a(CKB)3780000000101274
035   $a(OCoLC)1046110157
035   $a(SZ-BaSKA)221583
035   $a(EXLCZ)993780000000101274
100   $a20211006d1989      uy             0
101 0 $aeng
135   $aurunu|||||
200 10$aClinical Aspects of Calcium Entry Blockers / $f editor, P.A. van Zwieten
210   $aBasel : $cS. Karger, $d1989
215   $a1 online resource (XII + 200 pages) : $c  14 figures, 1 in color, 15 tables
225 0 $aProgress in Basic and Clinical Pharmacology, $x1662-3908 ; $vVol.2
311   $a3-8055-4858-3 
606   $aPharmacology
606   $aBiochemistry
606   $aEnzymology
606   $aToxicology
615 14$aPharmacology
615 24$aBiochemistry
615 24$aEnzymology
615 24$aToxicology
676   $a616.1/061
700   $avan Zwieten$b P.A$01215656
701  0$aZwieten$b P. A. van$01231371
801  0$bUKSKG
801  1$bUKSKG
906   $aBOOK
912   $a9910158699203321
996   $aClinical Aspects of Calcium Entry Blockers$92859060
997   $aUNINA